EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)—chemotherapy selected for multidrug resistance modulation
Author:
A Davidson,Gina Dick,K Pritchard-Jones,R Pinkerton
Publication:
European Journal of Cancer
Copyright © 2002 Elsevier Science Ltd. All rights reserved.